Meditrial is a leading Clinical Research Organization (CRO) focused on the needs of the MedTech industry. We are proud to serve the most innovative companies in the world. Our staff is recognized by customers and investigators as more expert, trustworthy and responsive – our people get the job done right.
“Win KOLs and work with partners” – virtual training by Dr. Monica Tocchi for VentureLab May 27, 2020 On 4th June 2020,
One million Covid-19 patients have returned to their homes after discharge from hospital.
A decision on the MDR delay to 2021 will be available as early as mid April. For Medtech manufacturers, what's the impact on your business?
In response to the Covid-19 emergency, the European Commission released a proposal to amend certain provisions of the Medical Device Regulation (EU) 2017/745.
Today’s live read-out by the European Commission spokesperson Stefan De Keersmaecker announced a proposal to delay the application of the new MDR.
As the COVID-19 emergency impacts all healthcare sectors, Meditrial provides rapid tools to help industry and researchers rescue their clinical trials.
We set up a Meditrial FREE HELPLINE, a tool to facilitate communication with our teams and address any particular questions or new requirements.
The New York City office is a brand new space to bring together people who share a dedication to innovation. Come visit the Training Center.
Complex new rules will impact the daily work of economic operators, healthcare professionals and health institutions. Learn how to get ready.
